The Sonalleve MR-HIFU (MR-guided High Intensity Focused Ultrasound) fibroid therapy system, by Philips, offers a non-invasive treatment for uterine fibroids. It combines the power of two modalities by integrating an advanced high intensity focused ultrasound system into the patient table of the Achieva MR system. It uses focused ultrasound waves to heat and coagulate tissue deep inside the body without damaging intervening tissue, and combines this with advanced planning, guidance and temperature monitoring provided by MR. The procedure can be performed on an outpatient basis, with an almost full recovery within a few days.
If you enjoy this content, please share it with a colleague
Related Content
Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...
Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...
Oct. 31, 2025 — Echolight plans to demonstrate its bone density scanning technology at the Radiological Society of North ...
Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...
Oct. 16, 2025 — Vave Health has introduced VaveEd, a hub for supporting ultrasound learning and education, alongside ...
Sept. 30, 2025 — Sona, the first free, HIPAA-compliant platform that securely delivers ultrasound images directly to ...
Sept. 15, 2025 — GE HealthCare has launched the Voluson Performance series, the latest addition to its women’s health ...
Sept. 4, 2025 — Ultrasound AI recently announced that the United States Patent and Trademark Office has issued U.S ...
Aug. 29, 2025 — GE HealthCare has launched Vivid Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ...
Aug. 12, 2025 —Sonic Incytes Medical Corp, has announced that the U.S. Food and Drug Administration (FDA) has granted ...
November 20, 2025 